| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-05001 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-09 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate |
2019-11-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662b1d3d175c76530de30e68744e19bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c0e319db461a487052d0562984023f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_842376c3fe28b4566b4c67d388f7b2f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_184090835aa5c25e4ece7abd276023ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2286b2deedb4d71ff433fdc2729952bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1736d1a51456a03c387983b1209974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6d9b53ae0da5222fe2cb81d8f2fe2c1 |
| publicationDate |
2020-06-25^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020199147-A1 |
| titleOfInvention |
Processes for preparing acc inhibitors and solid forms thereof |
| abstract |
which exhibits Acetyl-CoA carboxylase (“ACC”) inhibitory activity and may be useful in treating ACC mediated diseases. Also provided herein are processes or steps for the preparation of a Compound I and intermediates useful for the processes or steps described herein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578081-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673899-B2 |
| priorityDate |
2017-03-03^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |